scholarly journals Changes of Terminal Cancer Patients' Health-related Quality of Life after High Dose Vitamin C Administration

2007 ◽  
Vol 22 (1) ◽  
pp. 7 ◽  
Author(s):  
Chang Hwan Yeom ◽  
Gyou Chul Jung ◽  
Keun Jeong Song
Keyword(s):  
Quality Of Life ◽  
Vitamin C ◽  
Terminal Cancer ◽  
High Dose ◽  
Health Related Quality ◽  
Terminal Cancer Patients ◽  
Related Quality ◽  
Health Related ◽  
High Dose Vitamin

Health-related-quality-of-life and toxicity after single fraction 19 Gy high-dose-rate prostate brachytherapy: Phase II trial

2018 ◽  
Vol 126 (2) ◽  
pp. 278-282 ◽  
Author(s):  
Alfonso Gomez-Iturriaga ◽  
Francisco Casquero ◽  
Jose Ignacio Pijoan ◽  
Pablo Minguez ◽  
Jose Maria Espinosa ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Dose Rate ◽  
Phase Ii Trial ◽  
High Dose Rate ◽  
High Dose ◽  
Prostate Brachytherapy ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related

scholarly journals Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia

Antioxidants ◽  
2018 ◽  
Vol 7 (7) ◽  
pp. 92 ◽  
Author(s):  
Mike Foster ◽  
Anitra Carr ◽  
Alina Antony ◽  
Selene Peng ◽  
Mike Fitzpatrick
Keyword(s):  
Quality Of Life ◽  
Vitamin C ◽  
Health Related Quality ◽  
Cell Counts ◽  
Blood Cell Counts ◽  
Related Quality ◽  
Health Related ◽  
History Of ◽  
Acute Myeloid

A 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014). Intravenous(IV) vitamin C therapy was initiated (in 2014) following completion of chemotherapy as an alternative to haematopoietic stem cell transplantation. IV vitamin C was administered twice weekly at a dose of 70 g/infusion. Within 4 weeks of initiation of IV vitamin C therapy, there was a dramatic improvement in the patient’s blood indices with platelet cell counts increasing from 25 × 109/L to 196 × 109/L and white blood cell counts increasing from 0.29 × 109/L to 4.0 × 109/L, with further improvements observed over the next 18 months. Furthermore, there was a clear and sustained improvement in the patient’s health-related quality of life scores assessed using a validated questionnaire. She has remained healthy and in complete remission until the present day. This case study highlights the benefits of IV vitamin C as a supportive therapy for previously relapsed AML.

Sign in / Sign up

Export Citation Format

Share Document